Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Neurology
Published in: BMC Neurology 1/2014

Open Access 01-12-2014 | Study protocol

Internet-based guided self-help for glioma patients with depressive symptoms: design of a randomized controlled trial

Authors: Florien W Boele, Irma M Verdonck-de Leeuw, Pim Cuijpers, Jaap C Reijneveld, Jan J Heimans, Martin Klein

Published in: BMC Neurology | Issue 1/2014

Login to get access

Abstract

Background

Among glioma patients, depression is estimated to be more prevalent than in both the general population and the cancer patient population. This can have negative consequences for both patients and their primary informal caregivers (e.g., a spouse, family member or close friend). At present, there is no evidence from randomized controlled trials for the effectiveness of psychological treatment for depression in glioma patients. Furthermore, the possibility of delivering mental health care through the internet has not yet been explored in this population. Therefore, a randomized controlled trial is warranted to evaluate the effects of an internet-based, guided self-help intervention for depressive symptoms in glioma patients.

Methods/design

The intervention is based on problem-solving therapy. An existing 5-week course is adapted for use by adult glioma patients with mild to moderate depressive symptoms (Center for Epidemiology Studies Depression Scale score ≥12). Sample size calculations yield 126 glioma patients to be included, who are randomly assigned to either the intervention group or a waiting list control group. In addition, we aim to include 63 patients with haematological cancer in a non-central nervous system malignancy control group. Assessments take place at baseline, after 6 and 12 weeks, and after 6 and 12 months. Primary outcome measure is the change in depressive symptoms. Secondary outcome measures include health-related quality of life, fatigue, costs and patient satisfaction. In addition, all patients are asked to assign a primary informal caregiver, who does not participate in the intervention but who is asked to complete similar assessments. Their mood, health-related quality of life and fatigue is evaluated as well.

Discussion

This is the first study to evaluate the effects of problem-solving therapy delivered through the internet as treatment for depressive symptoms in glioma patients. If proven effective, this treatment will contribute to the mental health care of glioma patients in clinical practice.

Trial registration

Netherlands Trial Register NTR3223
Appendix
Available only for authorised users
Literature
1.
Mukand JA, Blackinton DD, Crincoli MG, Lee JJ, Santos BB: Incidence of neurologic deficits and rehabilitation of patients with brain tumors. Am J Phys Med Rehabil. 2001, 80: 346-10.1097/00002060-200105000-00005.CrossRefPubMed
2.
Taphoorn MJB, Klein M: Cognitive deficits in adult patients with brain tumors. Lancet Neurol. 2004, 3: 159-168. 10.1016/S1474-4422(04)00680-5.CrossRefPubMed
3.
Forsyth PA, Posner JB: Headaches in patients with brain tumors A study of 111 patients. Neurology. 1993, 43: 1678-10.1212/WNL.43.9.1678.CrossRefPubMed
4.
Pfund Z, Szapary L, Jaszberenyi O, Nagy F, Czopf J: Headache in intracranial tumors. Cephalalgia. 1999, 19: 787-790. 10.1046/j.1468-2982.1999.1909787.x.CrossRefPubMed
5.
Suwanwela N, Phanthumchinda K, Kaoropthum S: Headache in brain tumor: a cross-sectional study. J Head Face Pain. 1994, 34: 435-438. 10.1111/j.1526-4610.1994.hed3407435.x.CrossRef
6.
Rooney AG, Carson A, Grant R: Depression in cerebral glioma patients: a systematic review of observational studies. J Natl Cancer Inst. 2011, 103: 61-76. 10.1093/jnci/djq458.CrossRefPubMed
7.
Rooney AG, McNamara S, Mackinnon M, Fraser M, Rampling R, Carson A, Grant R: Frequency, clinical associations, and longitudinal course of major depressive disorder in adults with cerebral glioma. J Clin Oncol. 2011, 29: 4307-4312. 10.1200/JCO.2011.34.8466.CrossRefPubMed
8.
D'Angelo C, Mirijello A, Leggio L, Ferrulli A, Carotenuto V, Icolaro N, Miceli A, D'Angelo V, Gasbarrini G, Addolorato G: State and trait anxiety and depression in patients with primary brain tumors before and after surgery: 1 year longitudinal study. J Neurosurg. 2008, 108: 281-286. 10.3171/JNS/2008/108/2/0281.CrossRefPubMed
9.
Krebber AMH, Buffart LM, Kleijn G, Riepma IC, Bree R, Leemans CR, Becker A, Brug J, van Straten A, Cuijpers P, Verdonck-de Leeuw IM: Prevalence of depression in cancer patients: a meta-analysis of diagnostic interviews and self-report instruments. Psycho-Oncology. 2014, 23: 121-130. 10.1002/pon.3409.CrossRefPubMed
10.
Wellisch DK, Kaleita TA, Freeman D, Cloughesy T, Goldman J: Predicting major depression in brain tumor patients. Psycho-Oncology. 2002, 11: 230-238. 10.1002/pon.562.CrossRefPubMed
11.
Sherwood PR, Given BA, Given CW, Schiffman RF, Murman DL, Lovely M, von Eye A, Rogers LR, Remers S: Predictors of distress in caregivers of persons with a primary malignant brain tumor. Res Nurs Health. 2006, 29: 105-120. 10.1002/nur.20116.CrossRefPubMed
12.
Boele FW, Heimans JJ, Aaronson NK, Taphoorn MJ, Postma TJ, Reijneveld JC, Klein M: Health-related quality of life of significant others of patients with malignant CNS versus non-CNS tumors: a comparative study. J Neuro-Oncol. 2013, 115: 87-94. 10.1007/s11060-013-1198-z.CrossRef
13.
Janda M, Steginga S, Langbecker D, Dunn J, Walker D, Eakin E: Quality of life among patients with a brain tumor and their carers. J Psychosom Res. 2007, 63: 617-623. 10.1016/j.jpsychores.2007.06.018.CrossRefPubMed
14.
Armstrong TS, Cohen MZ, Eriksen LR, Hickey JV: Symptom clusters in oncology patients and implications for symptom research in people with primary brain tumors. J Nurs Scholarsh. 2004, 36: 197-206. 10.1111/j.1547-5069.2004.04038.x.CrossRefPubMed
15.
Valentine AD, Passik S, Massie MJ: Psychiatric and psychosocial issues. Cancer in the Nervous System. 2002, Oxford: University Press, 572-589. 2
16.
Anderson SI, Taylor R, Whittle IR: Mood disorders in patients after treatment for primary intracranial tumours. Br J Neurosurg. 1999, 13: 480-485.CrossRefPubMed
17.
Cuijpers P, Smit F, Van Straten A: Psychological treatments of subthreshold depression: a meta-analytic review. Acta Psychiatr Scand. 2007, 115: 434-441. 10.1111/j.1600-0447.2007.00998.x.CrossRefPubMed
18.
Rooney AG, Brown PD, Reijneveld JC, Grant R: Depression in glioma: a primer for clinicians and researchers. J Neurol Neurosurg Psychiatry. 2014, 85: 230-235. 10.1136/jnnp-2013-306497.CrossRefPubMed
19.
Singer S, Brown A, Einenkel J, Hauss J, Hinz A, Klein A, Papsdorf K, Stolzenburg JU, Brähler E: Identifying tumor patients’ depression. Support Care Cancer. 2011, 19: 1697-1703. 10.1007/s00520-010-1004-9.CrossRefPubMed
20.
Fallowfield L, Ratcliffe D, Jenkins V, Saul J: Psychiatric morbidity and its recognition by doctors in patients with cancer. Br J Cancer. 2001, 84: 1011-10.1054/bjoc.2001.1724.CrossRefPubMedPubMedCentral
21.
Mainio A, Hakko H, Timonen M, Niemelä A, Koivukangas J, Räsänen P: Depression in relation to survival among neurosurgical patients with a primary brain tumor: a 5-year follow-up study. Neurosurgery. 2005, 56: 1234-1242. 10.1227/01.NEU.0000159648.44507.7F.CrossRefPubMed
22.
Mainio A, Tuunanen S, Hakko H, Niemelä A, Koivukangas J, Räsänen P: Decreased quality of life and depression as predictors for shorter survival among patients with low-grade gliomas: a follow-up from 1990 to 2003. Eur Arch Psychiatry Clin Neurosci. 2006, 256: 516-521. 10.1007/s00406-006-0674-2.CrossRefPubMed
23.
Pelletier G, Verhoef MJ, Khatri N, Hagen N: Quality of life in brain tumor patients: the relative contributions of depression, fatigue, emotional distress, and existential issues. J Neuro-Oncol. 2002, 57: 41-49. 10.1023/A:1015728825642.CrossRef
24.
Pilling S, Anderson I, Goldberg D, Meader N, Taylor C: Guidelines: Depression in adults, including those with a chronic physical health problem: summary of NICE guidance. BMJ. 2009, 339: b4108-10.1136/bmj.b4108.CrossRefPubMedPubMedCentral
25.
Hart SL, Hoyt MA, Diefenbach M, Anderson DR, Kilbourn KM, Craft LL, Steel JL, Cuijpers P, Mohr DC, Berendsen M, Spring B, Stanton AL: Meta-analysis of efficacy of interventions for elevated depressive symptoms in adults diagnosed with cancer. J Natl Cancer Inst. 2012, 104: 990-1004. 10.1093/jnci/djs256.CrossRefPubMedPubMedCentral
26.
Litofsky NS, Farace E, Anderson F, Meyers CA, Huang W, Laws ER: Depression in patients with high-grade glioma: results of the glioma outcomes project. Neurosurgery. 2004, 54: 358-367. 10.1227/01.NEU.0000103450.94724.A2.CrossRefPubMed
27.
Cuijpers P, Donker T, Van Straten A, Li J, Andersson G: Is guided self-help as effective as face-to-face psychotherapy for depression and anxiety disorders? A systematic review and meta-analysis of comparative outcome studies. Psychol Med. 2010, 40: 1943-10.1017/S0033291710000772.CrossRefPubMed
28.
National Collaborating Centre for Mental Health: Depression: the Treatment and Management of Depression in Adults (updated edition). 2010
29.
Li M, Fitzgerald P, Rodin G: Evidence-based treatment of depression in patients with cancer. J Clin Oncol. 2012, 30: 1187-1196. 10.1200/JCO.2011.39.7372.CrossRefPubMed
30.
Mynors-Wallis L: Problem-Solving Treatment for Anxiety and Depression: A Practical Guide. 2005, Oxford: Oxford university press
31.
Mynors-Wallis LM, Gath DH, Lloyd-Thomas AR, Tomlinson DBMJ: Randomised controlled trial comparing problem solving treatment with amitriptyline and placebo for major depression in primary care. BMJ. 1995, 310: 441-10.1136/bmj.310.6977.441.CrossRefPubMedPubMedCentral
32.
Mynors-Wallis LM, Gath DH, Day A, Baker F: Randomised controlled trial of problem solving treatment, antidepressant medication, and combined treatment for major depression in primary care. BMJ. 2000, 320: 26-30. 10.1136/bmj.320.7226.26.CrossRefPubMedPubMedCentral
33.
Beltman MW, Voshaar RCO, Speckens AE: Cognitive- behavioural therapy for depression in people with a somatic disease: meta-analysis of randomised controlled trials. Br J Psychiatry. 2010, 197: 11-19. 10.1192/bjp.bp.109.064675.CrossRefPubMed
34.
Netherlands S: StatLine Database. 2013, Netherlands: Heerlen/Voorburg Statistics Netherlands
35.
Spek V, Cuijpers PIM, Nyklícek I, Riper H, Keyzer J, Pop V: Internet-based cognitive behaviour therapy for symptoms of depression and anxiety: a meta-analysis. Psychol Med. 2007, 37: 319-328. 10.1017/S0033291706008944.CrossRefPubMed
36.
Rooney A, Grant R: Pharmacological treatment of depression in patients with a primary brain tumour. Cochrane Database Syst Rev. 2010, 3: CD006932-PubMed
37.
Radloff LS: The CES-D scale a self-report depression scale for research in the general population. Appl Psychol Meas. 1977, 1: 385-401. 10.1177/014662167700100306.CrossRef
38.
Beck AT, Steer RA: Manual for the Beck Scale for Suicide Ideation. 1991, San Antonio, TX: Psychological Corporation
39.
Van Straten A, Cuijpers P, Smits N: Effectiveness of a web-based self-help intervention for symptoms of depression, anxiety, and stress: randomized controlled trial. J Med Internet Res. 2008, 10: e7-10.2196/jmir.954.CrossRefPubMedPubMedCentral
40.
Hann D, Winter K, Jacobsen P: Measurement of depressive symptoms in cancer patients: evaluation of the Center for Epidemiological Studies Depression Scale (CES-D). J Psychosom Res. 1999, 46: 437-443. 10.1016/S0022-3999(99)00004-5.CrossRefPubMed
41.
Aaronson NK, Muller M, Cohen PD, Essink-Bot ML, Fekkes M, Sanderman R, Sprangers MA, te Velde A, Verrips E: Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol. 1998, 51: 1055-1068. 10.1016/S0895-4356(98)00097-3.CrossRefPubMed
42.
Brooks R: EuroQol: the current state of play. Health Policy. 1996, 37: 53-72. 10.1016/0168-8510(96)00822-6.CrossRefPubMed
43.
Taphoorn MJ, Claassens L, Aaronson NK, Coens C, Mauer M, Osoba D, Stupp R, Mirimanoff RO, van den Bent MJ, Bottomley A: An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients. Eur J Cancer. 2010, 46: 1033-1040. 10.1016/j.ejca.2010.01.012.CrossRefPubMed
44.
Vercoulen JHM, Alberts M, Bleijenberg G: De Checklist Individuele Spankracht (CIS). Gedragstherapie. 1999, 32: 131-136.
45.
Steward AL, Ware JE: Measuring Functioning and Well-Being: The Medical Outcomes Study Approach. 1992, Duke: Duke University Press
46.
Hakkaart-van Roijen L, Straten A, Tiemens B, Donker MCH: Handleiding Trimbos/iMTA Questionnaire for Costs Associated with Psychiatric illness (TiC-P). 2002, Rotterdam: Institute of Medical Technology Assessment (iMTA), Erasmus Universiteit
47.
Hakkaart-van Roijen L: Handleiding Short Form-Health and Labour Questionnaire (SF-HLQ). 2010, Rotterdam: iMTA, Erasmus Universiteit
48.
Schafer JL: Multiple imputation: a primer. Stat Methods Med Res. 1999, 8: 3-15. 10.1191/096228099671525676.CrossRefPubMed
49.
50.
Newberry A, Sherwood P, Hricik A, Bradley S, Kuo J, Crago E, Hoffman LA, Given BA: Understanding recruitment and retention in neurological research. J Neurosci Nurs. 2010, 42: 47-10.1097/JNN.0b013e3181c1fdd9.CrossRefPubMedPubMedCentral
Metadata
Title
Internet-based guided self-help for glioma patients with depressive symptoms: design of a randomized controlled trial
Authors
Florien W Boele
Irma M Verdonck-de Leeuw
Pim Cuijpers
Jaap C Reijneveld
Jan J Heimans
Martin Klein
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2014
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/1471-2377-14-81

Other articles of this Issue 1/2014

BMC Neurology 1/2014 Go to the issue

Research article

Changes in lymphocyte subsets in patients with Guillain-Barré syndrome treated with immunoglobulin

Case report

The utility of exome sequencing for genetic diagnosis in a familial microcephaly epilepsy syndrome

Research article

High frequency of SPG4 in Taiwanese families with autosomal dominant hereditary spastic paraplegia

Research article

Glycated hemoglobin independently or in combination with fasting plasma glucose versus oral glucose tolerance test to detect abnormal glycometabolism in acute ischemic stroke: a Chinese cross-sectional study

Research article

Βeta-fibrinogen gene promoter A −455 allele associated with poor longterm survival among 55–71 years old Caucasian women in Finnish stroke cohort

Research article

The brief international cognitive assessment for multiple sclerosis (BICAMS): normative values with gender, age and education corrections in the Italian population